Discontinued — last reported Q2 '18
UnitedHealth Group Debt Instrument Face Amount decreased by 75.0% to $3.00B in Q2 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates higher leverage, while a decrease indicates debt repayment or deleveraging.
This represents the par or principal value of the company's debt instruments, excluding any premiums, discounts, or issu...
Standardized across all public companies with debt instruments on their balance sheet.
debt_instrument_face_amount| Q2 '22 | Q1 '23 | Q1 '24 | Q3 '24 | Q2 '25 | |
|---|---|---|---|---|---|
| Value | $6.00B | $6.50B | $6.00B | $12.00B | $3.00B |
| QoQ Change | — | +8.3% | -7.7% | +100.0% | -75.0% |
| YoY Change | — | — | -7.7% | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.